Sign Up Today and Learn More About Aravax Stock
Invest in or calculate the value of your shares in Aravax or other pre-IPO companies through EquityZen's platform.
Aravax Stock
Aravax is an early stage biotechnology company focused on developing the first safe and rapidly effective treatment for peanut allergy.
About Aravax Stock
Founded
2015
Industries
Aravax Press Mentions
Stay in the know about the latest news on Aravax
Biotech Aravax raises $66m for peanut allergy cure
businessnewsaustralia • May 05, 2024
Aravax taps MinterEllison on US$68m Series B raising
thelawyermag • May 05, 2024
Aravax secures $22M to close series B for peanut allergy therapy
bioworld • Feb 06, 2024
Peanut Allergy Treatment Industry Assessment 2023-2030 ...
finance • Dec 20, 2023
Six biotech companies in Melbourne making the news
labiotech • Dec 20, 2023
Aravax Management
Leadership team at Aravax
CEO
Pascal Hickey
Chief Operating Officer and Co-Founder
Sara Prickett
Join now and verify your accreditation status to gain access to:
- Aravax current valuation
- Aravax stock price
- Available deals in Aravax and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Aravax stock?
Accredited investors can buy pre-IPO stock in companies like Aravax through EquityZen funds. These investments are made available by existing Aravax shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Aravax stock?
Shareholders can sell their Aravax stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
